Irinotecan and Carboplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer

NCT00469898 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: Carboplatin
DRUG: irinotecan hydrochloride

Sponsor

Vanderbilt-Ingram Cancer Center

Collaborators

[object Object]